| revenue | $26.275-26.475 billion | FY2026 | tight_range | New |
| SG&A as a percent of revenue | around 10% | FY2026 | point | New |
| margin | 31-31.2% | FY2026 | tight_range | New |
| synergies | more than $300 million | through end of 2027 | directional | New |
| core price | above 5.5% | exit 2026 | directional | New |
| SG&A in Healthcare Solutions | 15-16% | by end of 2026 | tight_range | New |
| Collection and Disposal volumes | relatively flat | second-half 2026 | directional | New |
| Collection and Disposal volumes | approaching 1% | FY2026 | directional | New |
| Collection and Disposal yield | high end of guidance | FY2026 | directional | New |
| energy surcharge revenue | higher than expected | FY2026 | directional | New |
| residential volume declines | moderate | coming quarters | directional | New |
| residential volume losses | moderate | coming quarters | directional | New |
| energy surcharges | $175 million | FY2026 | point | New |
| Collection and Disposal revenue impact from volume | $250 million | FY2026 | point | New |
| Collection and Disposal net impact from volume and surcharges | $75 million | FY2026 | point | New |
| Collection and Disposal volumes | flattish | second-half 2026 | directional | New |
| Collection and Disposal volumes | negative 0.8% | FY2026 | point | New |
| Collection and Disposal volumes | positive 0.4% | FY2026 | point | New |
| landfill gas outlook | lighter than anticipated | FY2026 | directional | New |
| landfill gas outlook | confident in ability to deliver | 2027 | directional | New |
| residential churn | moderate | end of 2027 | directional | New |
| residential churn | flat to positive | middle to end of 2027 | directional | New |
| margin | elevated | second-half 2026 | directional | New |
| margin | continued expansion | second-half 2026 | directional | New |
| Healthcare Solutions price | 5.7% | exit 2026 | point | New |
| Healthcare Solutions price | 4.5% | Q2 2026 | point | New |
| Healthcare Solutions revenue growth | moderate | second-half 2026 | directional | New |
| Healthcare Solutions SG&A | sub-20% | second-half 2026 | directional | New |
| Healthcare Solutions SG&A | 15-16% | second-half 2026 | tight_range | New |
| price-cost spread | outperformed 250 basis points | Q2 2026 | directional | New |
| RINs volume locked up | 90% | 2026 | point | New |
| RINs pre-sold | one-third | 2027 | point | New |
| RNG production run rate | 25 million MMBtu | FY2026 | point | New |